Rationale for the development of immunotherapy regimens against enterococcal infections.
about
Phage therapy against Enterococcus faecalis in dental root canalsSynthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteriaImmunochemical characterization of polysaccharide antigens from six clinical strains of Enterococci.Large-scale screening of a targeted Enterococcus faecalis mutant library identifies envelope fitness factors.Targeting pili in enterococcal pathogenesis.Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acidAutomated solid phase synthesis of teichoic acids.Potential targets for next generation anti-microbial glycoconjugate vaccines.
P2860
Q28071930-141E6196-1156-4A0D-A72B-F94535D2BCC2Q28543983-3E247D82-B860-4EC4-A312-9E666B701C47Q33249929-BDEE307C-A133-4328-AA3D-49C2DD1B54A7Q34110655-462F8397-A2B4-40CF-991D-4B8F48D517D2Q37713275-C5235E6A-3E30-4A31-B4F2-EA0C0958A80AQ38484159-11F3C68E-D269-4E64-81D1-3E9EB10A4FDFQ39731499-ED1806A7-3CC1-41FB-8614-C5C051C64B25Q53701548-630CEEB1-99F8-4C26-B4A5-DF70CE3BBF89
P2860
Rationale for the development of immunotherapy regimens against enterococcal infections.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Rationale for the development of immunotherapy regimens against enterococcal infections.
@ast
Rationale for the development of immunotherapy regimens against enterococcal infections.
@en
type
label
Rationale for the development of immunotherapy regimens against enterococcal infections.
@ast
Rationale for the development of immunotherapy regimens against enterococcal infections.
@en
prefLabel
Rationale for the development of immunotherapy regimens against enterococcal infections.
@ast
Rationale for the development of immunotherapy regimens against enterococcal infections.
@en
P2093
P1433
P1476
Rationale for the development of immunotherapy regimens against enterococcal infections
@en
P2093
Andrea Kropec
Johannes Huebner
Wolfgang A Krueger
P356
10.1016/J.VACCINE.2004.08.014
P407
P478
22 Suppl 1
P577
2004-12-01T00:00:00Z